[Federal Register Volume 62, Number 234 (Friday, December 5, 1997)]
[Notices]
[Pages 64391-64392]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31832]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: Coronary Stent Angioplasty: Factors Affecting 
Restenosis (Telephone Conference Call).
    Date: January 6, 1998.
    Time: 9:00 a.m.
    Place: 6701 Rockledge Drive, Room 7214, Bethesda, Maryland 
20892.
    Contact Person: C. James Scheirer, Ph.D., Two Rockledge Center, 
Room 7220, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0266.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Specialized Centers of Research in Acute Lung 
Injury.
    Date: January 7-8, 1998.
    Time: 8:00 a.m.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, Maryland 20815.
    Contact Person: Anne P. Clark, Ph.D., Two Rockledge Center, Room 
7186, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0280.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Specialized Centers of Research in Neurobiology of 
Sleep and Sleep Apnea.

[[Page 64392]]

    Date: January 8, 1998.
    Time: 8:30 a.m.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, 
Virginia 22209.
    Contact Person: S. Charles Selden, Ph.D., Two Rockledge Center, 
Room 7196, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0288.
    Purpose/Agenda: To review and evaluate grant applications.

    These meetings will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: November 30, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-31832 Filed 12-4-97; 8:45 am]
BILLING CODE 4140-01-M